Premier Farnell’s New CAD Tool Interface, DesignLink, Enables Electronic Design Engineers to Find and Specify Millions of Parts Directly from within the Design Environment
CAD Tool Vendors Invited to Partner with Global Electronics Distributor to Provide This Benefit
Premier Farnell’s New CAD Tool Interface, DesignLink, Enables
Electronic
Design Engineers to Find and Specify Millions of
Parts
Directly from within the Design Environment
Premier Farnell plc (LSE:pfl), the leading multi-channel, high service distributor supporting millions of engineers and purchasing professionals worldwide, has introduced DesignLink, a new web service environment that provides an electronic interface to major CAD (Computer Aid Design) tools. This will allow electronic designer engineers to immediately search and find parts from within their CAD design environment without ever having to leave it.
Developed in close collaboration with EMA, the developer of Component Information Portal (CIP), a bridge software to Cadence’s OrCAD CAD tool, the new Coupling Interface allows the designer to take the manufacturer’s data and use it directly in their schematic design instead of the having to research them via the web; they can also be sure that they are using active parts and then simply import part attributes into the design or local parts database. The coupling interfaces directly with the Premier Farnell companies’ websites in 40 different countries giving access to over 4,000,000 items from 3,500 leading manufacturers, all with data and pricing in local language and currencies, and further underpins the distribution group’s commitment to understanding the needs of its design engineering customers and delivering leading edge solutions. The Group’s strategic direction has seen it focussed on providing products, information, software and services to meet the needs of electronic design engineers globally and DesignLink represents another major advance.
Randall Restle, Director of Global Technical Marketing, said: "This new capability maps out the future of integration in the design cycle. Our customers are the same as those of the CAD vendors and DesignLink will allow us to support them better in the early stages of the design cycle. It seamlessly links everything together; allowing a designer to see what parts can fit his design by part or keyword search. He can then check availability for next day delivery without ever having to leave his design environment – it integrates our product database right into the design environment. We invite CAD tool developers to get in touch so we can help them to integrate our extensive product database into their CAD tools. Our beta testing has indicated that designers love this product and it will become a key "must have" during CAD tool choice."
Premier Farnell invites all manufacturers of CAD tools to contact them directly to discuss implementing the DesignLink interface with their design environment. The Group will be rapidly increasing their global capability to interface with a wide range of CAD platforms this year as they expand their support to meet the unique needs of their electronic design engineering customers.
Whether CAD tool manufacturer or electronic design engineer, to learn more about this exciting new development, e-mail DesignLink@premierfarnell.com .
element14 , a new technical portal and community for design engineers, provides a unique platform from which to launch new design tools and reach millions of electronic design engineers world-wide. A range of CAD Tools for electronic design engineers will also soon be available on element14. To follow or comment on this latest innovation visit www.element-14.com .
About Premier Farnell
Premier Farnell plc (LSE:pfl) is a leading high service, multi-channel distributor of electronic, and industrial products and specialist services throughout Europe, the Americas and Asia Pacific. It goes to market with a differentiated value proposition, world-class marketing, a stocked range of 450,000+ products, and access to 4,000,000 more items from 3,500 top manufacturers. The company has group sales of £823.1m and over 4,100 employees globally.
While global in scope, Premier Farnell recognizes the individual needs of each market and has continued to internationalize its model accordingly, trading locally under different brand names. Its primary electronics businesses trade as Farnell in the UK, India, Europe, Australia and New Zealand, Newark in the US, Canada and Mexico, and Premier Electronics in China and Hong Kong. In Singapore, Malaysia, and Brazil the operation is known as Farnell Newark.
For more information visit the website at www.PremierFarnell.com .
- End -
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Contact:
Jenny Peters
Head of Corporate Communication
Premier
Farnell plc, and Asia
Tel: +44 (0) 207 851 4102
Email: jpeters@premierfarnell.com
Web:
www.premierfarnell.com
or
Jonathan
Roberts
Account Director
Pinnacle Marketing
Communications Ltd,
Tel: +44 (0) 208 429 6540
Email: jonathan@pinnaclemarcom.com
Web:
www.pinnaclemarcom.com
or
Janice
Fleisher
PR & Communications Manager
Newark
The
Americas
Tel: +001 (1) 773 907 5941
Email: jfleisher@newark.com
Web:
www.newark.com
or
Philip
Crampton
Marketing Manager
Farnell
Europe
Tel:
+44 (0) 113 279 0101 ext 3433
Email: pcrampton@premierfarnell.com
Web :
www.farnell.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom